---
schema_version: "secwatch.filing_event.v1"
accession: "0001636282-24-000058"
form_type: "8-K/A"
ticker: "SYRE"
cik: "0001636282"
company_name: "Spyre Therapeutics, Inc."
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T10:58:00.402650+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.0
calibrated_materiality_score: 0.0
confidence: "low"
source: SEC EDGAR
---

# Spyre Therapeutics files 8-K/A to correct date on cover page of prior filing

## Summary
- Amendment corrects clerical error on cover page date of Original 8-K filed August 7, 2024.
- No changes to financial results, disclosures, or exhibits from the original report.
- Original 8-K reported Q2 2024 financials; this filing only revises the report date.
- No new material information for investors; purely administrative correction.

## SEC filing metadata
- accession: 0001636282-24-000058
- form_type: 8-K/A
- ticker: SYRE
- cik: 0001636282
- company_name: Spyre Therapeutics, Inc.
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.0
- calibrated_materiality_score: 0.0
- confidence: low
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636282/000163628224000058/0001636282-24-000058-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636282/000163628224000058/syre-20240807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001636282-24-000058
- JSON: https://secwatch.observer/filing/0001636282-24-000058.json
- Plain text: https://secwatch.observer/filing/0001636282-24-000058.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.